On November 13, 2017, the Federal Motor Carrier Safety Administration published a Final Rule to amend its drug testing program to add four opioids: hydromorphone, hydrocodone, oxymorphone, and oxycodone to the drug testing panel.   This Final Rule becomes effective on January 1, 2018 and Commercial Driver’s License (CDL) qualified drivers who are subject to mandatory testing pursuant to the Federal Motor Carrier Safety Administration will be affected by this regulatory revision.

If you have questions or would like additional information concerning this matter, contact the IBT Safety and Health Department at (202) 624-6960 or visit the IBT Safety and Health webpage at www.teamstersafety.org.

• Share on Facebook
• Share on Twitter
• Share via email